We are live on
!
Find out more
AC
Ascend Capital Portfolio holdings
AUM
$1.99B
1-Year Est. Return
10.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$3.28B
AUM Growth
+$597M
(+22%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
5.04%
Top 10 Holdings %
Top 10 Hldgs %
22.55%
Holding
268
New
71
Increased
59
Reduced
39
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$77.8M |
| 2 |
Host Hotels & Resorts
HST
|
+$67.9M |
| 3 |
Wynn Resorts
WYNN
|
+$64.1M |
| 4 |
International Paper
IP
|
+$63.6M |
| 5 |
Advance Auto Parts
AAP
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$58.5M |
| 2 |
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
|
+$57.9M |
| 3 |
Travel + Leisure Co
TNL
|
+$56M |
| 4 |
ONIT
Onity Group
ONIT
|
+$44.1M |
| 5 |
Eagle Materials
EXP
|
+$42.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.75% |
| 2 | Healthcare | 13.67% |
| 3 | Technology | 10.55% |
| 4 | Financials | 10.48% |
| 5 | Materials | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUB.B
51
DELISTED
HUBBELL INC CL-B
HUB.B
| $22.2M | 0.68% |
204,085
+169,328
| +487% | +$18.1M |
|
|
52
CALL
Teva Pharmaceuticals
TEVA
$35.9B
| $22M | 0.67% |
+550,000
| New | +$21.7M |
|
|
JAH
53
DELISTED
JARDEN CORPORATION
JAH
| $20.9M | 0.64% |
510,288
-237,755
| -32% | -$8.63M |
|
54
GameStop
GME
$9.5B
| $20M | 0.61% |
+1,626,796
| New | +$20.9M |
|
55
Best Buy
BBY
$18B
| $19.9M | 0.61% |
500,000
-150,000
| -23% | -$6.15M |
|
56
Meta Platforms (Facebook)
META
$1.51T
| $19.3M | 0.59% |
353,400
+9,400
| +3% | +$472K |
|
|
NE
57
DELISTED
Noble Corporation
NE
| $19.2M | 0.58% |
+586,151
| New | +$19.5M |
|
|
ARRS
58
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $18.8M | 0.57% |
772,417
+247,799
| +47% | +$4.73M |
|
|
IM
59
DELISTED
Ingram Micro
IM
| $18.2M | 0.55% |
776,700
+338,700
| +77% | +$7.94M |
|
60
iShares MSCI Japan ETF
EWJ
$21.7B
| $18.2M | 0.55% |
374,750
+290,750
| +346% | +$13.9M |
|
61
American International
AIG
$41.9B
| $17.9M | 0.54% |
350,000
-241,086
| -41% | -$12M |
|
62
Huntsman Corp
HUN
$2.24B
| $17.7M | 0.54% |
718,902
-699,943
| -49% | -$15.9M |
|
|
TIVO
63
DELISTED
TIVO INC
TIVO
| $17.3M | 0.53% |
1,321,000
+467,010
| +55% | +$6.04M |
|
64
Herc Holdings
HRI
$5.43B
| $17.3M | 0.53% |
+201,246
| New | +$14.4M |
|
65
Gaming and Leisure Properties
GLPI
$12.8B
| $17.3M | 0.53% |
+340,000
| New | +$16.2M |
|
|
SWY
66
DELISTED
SAFEWAY INC
SWY
| $16.3M | 0.5% |
+558,817
| New | +$16.8M |
|
67
LyondellBasell Industries
LYB
$19.5B
| $16.2M | 0.49% |
201,617
+76,887
| +62% | +$5.89M |
|
68
United Airlines
UAL
$38.4B
| $16.1M | 0.49% |
425,057
+225,458
| +113% | +$7.9M |
|
69
Bristol-Myers Squibb
BMY
$127B
| $15.9M | 0.49% |
+300,000
| New | +$15.3M |
|
|
VIAB
70
DELISTED
Viacom Inc. Class B
VIAB
| $15.7M | 0.48% |
180,000
+151,629
| +534% | +$12.5M |
|
|
UFS
71
DELISTED
DOMTAR CORPORATION (New)
UFS
| $15.6M | 0.48% |
+330,994
| New | +$14.4M |
|
72
MasTec
MTZ
$26.7B
| $15.5M | 0.47% |
+472,206
| New | +$14.9M |
|
73
Eaton
ETN
$157B
| $15.2M | 0.46% |
200,000
+100,000
| +100% | +$7.11M |
|
74
Fidelity National Financial
FNF
$13.9B
| $14.9M | 0.45% |
+803,737
| New | +$13M |
|
|
CHMT
75
DELISTED
Chemtura Corporation
CHMT
| $14.8M | 0.45% |
+531,343
| New | +$13.3M |
|
Similar funds
MWAC
TP
PC
RW
TBC
BWCA
AC
GCM
Ascend Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Ascend Capital held 268 positions worth $3.28B, up 22% from $2.69B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ascend Capital deployed $166M of net new capital in Q4 2013, opening 71 new positions and adding to 59 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $57.9M trimmed.
- Ascend Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.
- Ascend Capital added most to Host Hotels & Resorts in Q4 2013, an estimated $67.9M increase.
- Ascend Capital's biggest Q4 2013 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $57.9M.
- Ascend Capital fully exited Perrigo in Q4 2013, selling an estimated $58.5M.
- Ascend Capital's ten largest holdings make up 23% of its $3.28B portfolio in Q4 2013.
- Ascend Capital opened 71 new positions and closed 90 in Q4 2013.
- Ascend Capital's portfolio value rose 22% quarter-over-quarter to $3.28B.
Based on Ascend Capital's 13F filing for Q4 2013, filed 14 Feb 2014.